Sex, race and ethnicity: Providing quality care for elderly patients hospitalized with heart failure

Aging Health

Volumn 5, Issue 2, 2009, Pages 171-176

  Ghali, Jalal K ^a  

^a HARPER UNIVERSITY HOSPITAL   (United States)

Author keywords

Elderly; Heart failure; Quality of care; Race and ethnicity guidelines; Sex and gender

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HYDRALAZINE; NITRATE;

AGED; AGING; ARTICLE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR SYSTEM; CLINICAL TRIAL; ETHNICITY; EVIDENCE BASED MEDICINE; GERIATRIC CARE; HEALTH CARE QUALITY; HEART FAILURE; HEART MUSCLE RELAXATION; HUMAN; PREVALENCE; PROGNOSIS; PUBLIC HEALTH PROBLEM; QUALITY OF LIFE; RACE DIFFERENCE; SEX DIFFERENCE;

EID: 70249103132     PISSN: 1745509X     EISSN: 17455103     Source Type: Journal    
DOI: 10.2217/ahe.09.7     Document Type: Article

References (43)

1. Rosamond W, Flegal K, Furie K et al.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart Disease and Stroke Statistics 2008 Update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommitee. Circulation 117, E25-E146 (2008).
2. Hunt SA, Abraham WT, Chin MH et al.: ACC/AHA 2005 guideline update for the diagnosis and management chronic heart failure in the adult: Circulation 112, E154-E235 (2005).
3. Adams KF, Lindenfeld J, Arnold JM et al.: HFSA 2006 Comprehensive Heart Failure Practice Guideline. J. Card. Fail. 12, E1-E119 (2006).
4. European Society of Cardiology; Heart Failure Association of the ESC (HFA); European Society of Intensive Care Medicine (ESICM); Dickstein K, Cohen-Solal A, Filippatos G et al.: ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur. J. Heart Fail. 10(10), 933-989 (2008).
5. Malcom J, Arnold O, Howlett JG et al.: Canadian Cardiovascular Society. Canadian Cardiovascular Society Consensus Conference guidelines on heart failure - 2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies. Can. J. Cardiol. 24(1), 21-40 (2008).
6. Ghali JK: A clinician's perspective on clinical trials. J. Card. Fail. 7, 1-3 (2001).
7. Heiat A, Gross CP, Krumholz HM: Representation of the elderly, women and minorities in heart failure clinical trials. Arch. Intern. Med. 162, 1682-1688 (2002).
8. Senni M, Tribouilloy CM, Rodeheffer RJ et al.: Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation 98, 2282-2289 (1998).
9. Ghali JK, Kitzman DW: Heart failure in the elderly. In: Managing Acute Decompensated Heart Failure. O'Conner CM, Stough WG, Gheorghiade M, Adams KF Jr (Eds). Taylor & Francis, Boca Raton, FL, USA, 71-82 (2005).
10. Schulman SP, Lakatta EG, Fleg JL et al.: Age-related decline in left ventricular filling at rest and exercise. Am. J. Physiol. 263, H1932-H1938 (1992).
11. Ziegler MG, Lake CR, Kopin IJ: Plasma noradrenaline increases with age. Nature 261, 333-335 (1976).
12. White M, Roden R, Minobe W et al.: Age-related changes in β-adrenergic neuroeffector systems in the human heart. Circulation 90, 1225-1238 (1994).
13. Tsunoda K, Abe K, Goto T et al.: Effect of age on the renin - angiotensin - aldosterone system in normal subjects: simultaneous measurements of active and inactive rennin, rennin substrate, and aldosterone in plasma. J. Clin. Endocrinol. Metab. 62, 384-389 (1986).
14. Stratton JR, Cerquerira MD, Schwartz RS et al.: Differences in cardiovascular responses to isoproterenol in relation to age and exercise training in healthy men. Circulation 86, 504-512 (1992).
15. O'Brien IAD, O'Hare P, Corrall RJM: Heart rate variability in health subjects: effect of age and the derivation of normal ranges for tests of autonomic function. Br. Heart J. 55, 348-354 (1985).
16. Cody RJ, Torre S, Clark M, Pondolfino K: Age-relatated hemodynamic, renal and hormonal differences among patients with congestive heart failure. Arch. Intern. Med. 149, 1023-1028 (1989).
17. Havranek EP, Masoudi FA, Westfall KA, Wolfe P, Ordin DL, Krumholz HM: Spectrum of heart failure in older patients: results from the National Heart Failure Project. Am. Heart J. 143, 412-417 (2002).
18. Go AS, Yang J, Gurwitz JH et al.: Comparative effectiveness of different β-adrenergic antagonists on mortality among adults with heart failure in clinical practice. Arch. Intern. Med. 168(22), 2415-2421 (2008).
19. Kramer JM, Curtis LH, Dupree CS et al.: Comparative effectiveness of β-blockers in elderly patients with heart failure. Arch. Intern. Med. 168(22), 2422-2428 (2008).
20. Institute of Medicine: Exploring the Biological Contributions to Human Health: Does Sex Matter? National Academy Press, Washington, DC, USA (2001).
21. Ghali JK: Sex-related differences in heart failure and β-blockers. Heart Fail. Rev. 2, 149-159 (2004).
22. Laird R, Weiss SO, Lindenfeld J: The female patient. Heart Fail. Women 23, 46-55 (2005).
23. Ghali JK. Sex related differences in heat failure. In: Managing Acute Decompensated Heart Failure. O'Conner CM, Stough WG, Gheorghiade M, Adams KF Jr (Eds). Taylor & Francis, Boca Raton, FL, USA, 53-70 (2005).
24. Ghali JK, Lindenfeld J: Sex differences in response to chronic heart failure therapies. Expert Cardiovasc. Ther. 6(4), 555-565 (2008).
25. Hudson M, Rahme E, Behlouli H et al.: Sex differences in the effectiveness of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in patients with congestive heart failure - a population study. Eur. J. Heart Fail. 9, 602-609 (2007).
26. Hernandez AF, Fonarow GC, Liang L et al.: Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. JAMA 298(13), 1525-1532 (2007).
27. El-Chami MF, Hanna IR, Bush H, Langbert JJ: Impact of race and gender on cardiac device implantations. Heart Rhythm 4, 1420-1426 (2007).
28. The American Heritage Dictionary of the English Language. New College Edition. Houghton Mifflin, Boston, MA, USA (1981).
29. Schwartz RS: Racial profiling in medical research. N. Engl. J. Med. 344, 1392-1393 (2001).
30. American Anthropology Association; AAA statement on race. Am. Anthropol. 100, 712-713 (1998).
31. Yancy CW, Sica DA: Cardiovascular disease in African-Americans. J. Clin. Hypertens. (Greenwich) 6, 54-56 (2004).
32. Skinner J, Chandra A, Staiger D, Lee J, McClellan M: Mortality after acute myocardial infarction in hospitals that disproportionately treat Black patients. Circulation 112, 2634-2641 (2005).
33. Alexander M, Grumbach K, Remy L, Rowell R, Massie BM: Congestive heart failure hospitalizations and survival in California: patterns according to race/ethnicity. Am. Heart J. 137, 919-927 (1999).
34. Jha AK, Shlipak MG, Hosmer W, Frances CD, Browner WS: Racial differences in mortality among men hospitalized in the Veterans Affairs healthcare system. JAMA 285, 297-303 (2001).
35. Rathore SS, Foody JM, Wang Y et al.: Race, quality of care and outcomes of elderly patients hospitalized with heart failure. JAMA 289, 2517-2524 (2003).
36. Deswal A, Petersen NJ, Souchek J et al.: Impact of race on health care utilization and outcomes in veterans with congestive heart failure. J. Am. Coll. Cardiol. 42, 778-784 (2004).
37. Polsky D, Lave J, Klusaritz H, Jha A et al.: Is lower 30-day mortality posthospital admission among Blacks unique to the Veterans Affairs health care system? Med. Care 45, 1083-1089 (2007).
38. Yancy CW, Abraham WT, Albert NM et al.: Quality of care of and outcomes for African-Americans hospitalized with heart failure. J. Am. Coll. Cardiol. 51, 1675-1684 (2008).
39. Taylor AL, Ziesche S, Yancy C et al.: Combination of isosorbide dinitrate and hydralazine in Blacks with heart failure. N. Engl. J. Med. 351, 2049-2057 (2004).
40. Pitt B, Remme W, Zannad F et al.: Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N. Engl. J. Med. 348, 1309-1321 (2003).
41. Pitt B, Poole-Wilson PA, Segal R et al.: Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomized. trial: the Losartan Heart Failure Survival Study ELITE II. Lancet 355, 1582-1587 (2000).
42. Kfoury AG, French TK, Horne BD et al.: Incremental survival benefit with adherence to standardized heart failure core measures: a performance evaluation study of 2598 patients. J. Card. Fail. 14, 95-102 (2008).
43. Gattis WA, O'Connor CM, Gallup DS, Hasselblad V, Gheorghiad M; IMPACT-HF Investigators and Coordinators: Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial. J. Am. Coll. Cardiol. 43(9), 1534-1541 (2004).